Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mojoon vs TeleDocs360

Mojoon
Graded #475

Lower grade

vs+2.3000000000000043
TeleDocs360
Graded #444

Higher grade

The verdict

TeleDocs360 takes it — 55.2/100 to 52.9/100.

TeleDocs360 grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleDocs360 is a cash-pay telehealth service offering compounded GLP-1 weight loss medications, including injectable semaglutide and tirzepatide, oral semaglutide, plus phentermine and NAD+ therapy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMojoon +3
30
27
Dose & formulationTeleDocs360 +23
52
75
Clinical oversightTeleDocs360 +10
74
84
Labs & monitoringMojoon +1
53
52
FulfillmentMojoon +5
65
60
Contract termsMojoon +35
55
20
Mojoon · left barTeleDocs360 · right bar

The numbers

MetricMojoonTeleDocs360
WeighScore52.9/10055.2/100
GradeCC
Scorecard rank#475#444
Semaglutide$450/mo (starting dose, compounded)$399/mo (compounded)
TirzepatideNot disclosed$399/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Mojoon

Graded #475 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Premium pricing relative to market
TeleDocs360

Graded #444 · C

Strengths

  • Transparent $399/month base pricing for standard dosing
  • Multiple GLP-1 options including injectable and oral semaglutide
  • Cash-pay model with HSA/FSA card acceptance
  • Fast online intake and 24-hour prescription approval
  • Cancel anytime between shipments

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • No individual provider credentials or board certifications shown
  • Higher doses increase cost

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard